3Helix
3Helix commercializes labeled collagen hybridizing peptide (CHP) that specifically binds to such unfolded collagen chains, enabling unlimited laboratory applications in pathology, biomechanics, cell biology, regenerative medicine, and more. 3Helix is advancing its compounds to enable new pathways to achieving diagnostic and therapeutic objectives.
Company Ownership:
Socially Disadvantaged
Contact Name:
Yang Li
Contact Email:
Website:
https://www.3helix.com/
City, State – Congressional District:
Salt Lake City,
UT
–
1
Technology:
Diagnostic
Funding:
Research Infrastructure (ORIP)
NIH Projects:
NIH RePorter for
3Helix
Sponsored Event(s):
Life Sciences Summit | 2021
